Inflammatory Breast Neoplasms [clinicaltrials_resource:dd5979061748d9e407dd4e62ead9f247]
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer [clinicaltrials:NCT00003680]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer [clinicaltrials:NCT00005822]Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [clinicaltrials:NCT00016276]clinicaltrials:NCT00016549clinicaltrials:NCT00017095Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [clinicaltrials:NCT00049114]Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [clinicaltrials:NCT00066443]Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [clinicaltrials:NCT00070252]clinicaltrials:NCT00105950Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer [clinicaltrials:NCT00111787]clinicaltrials:NCT00118053clinicaltrials:NCT00193050clinicaltrials:NCT00193206Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [clinicaltrials:NCT00251329]clinicaltrials:NCT00256243Establishing an Inflammatory Breast Cancer Registry [clinicaltrials:NCT00340158]Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia [clinicaltrials:NCT00344071]Inflammatory Breast Cancer (IBC) Registry [clinicaltrials:NCT00477100]clinicaltrials:NCT00513695clinicaltrials:NCT00558103Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis [clinicaltrials:NCT00646555]clinicaltrials:NCT00756470Case-Control Study of Inflammatory Breast Cancer in North Africa [clinicaltrials:NCT00793390]clinicaltrials:NCT00820547Dose-escalation Study of Oral CX-4945 [clinicaltrials:NCT00891280]MUC1 Vaccine for Triple-negative Breast Cancer [clinicaltrials:NCT00986609]clinicaltrials:NCT01036087Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy [clinicaltrials:NCT01038258]MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer [clinicaltrials:NCT01231386]clinicaltrials:NCT01262027Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer [clinicaltrials:NCT01325428]Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [clinicaltrials:NCT01417286]clinicaltrials:NCT01426880Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer [clinicaltrials:NCT01525966]clinicaltrials:NCT01583426clinicaltrials:NCT01641406clinicaltrials:NCT01880385
condition browse [clinicaltrials_vocabulary:condition-browse]
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer [clinicaltrials:NCT00003680]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer [clinicaltrials:NCT00005822]Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [clinicaltrials:NCT00016276]clinicaltrials:NCT00016549clinicaltrials:NCT00017095Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [clinicaltrials:NCT00049114]Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [clinicaltrials:NCT00066443]Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [clinicaltrials:NCT00070252]clinicaltrials:NCT00105950Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer [clinicaltrials:NCT00111787]clinicaltrials:NCT00118053clinicaltrials:NCT00193050clinicaltrials:NCT00193206Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [clinicaltrials:NCT00251329]clinicaltrials:NCT00256243Establishing an Inflammatory Breast Cancer Registry [clinicaltrials:NCT00340158]Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia [clinicaltrials:NCT00344071]Inflammatory Breast Cancer (IBC) Registry [clinicaltrials:NCT00477100]clinicaltrials:NCT00513695clinicaltrials:NCT00558103Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis [clinicaltrials:NCT00646555]clinicaltrials:NCT00756470Case-Control Study of Inflammatory Breast Cancer in North Africa [clinicaltrials:NCT00793390]clinicaltrials:NCT00820547Dose-escalation Study of Oral CX-4945 [clinicaltrials:NCT00891280]MUC1 Vaccine for Triple-negative Breast Cancer [clinicaltrials:NCT00986609]clinicaltrials:NCT01036087Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy [clinicaltrials:NCT01038258]MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer [clinicaltrials:NCT01231386]clinicaltrials:NCT01262027Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer [clinicaltrials:NCT01325428]Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [clinicaltrials:NCT01417286]clinicaltrials:NCT01426880Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer [clinicaltrials:NCT01525966]clinicaltrials:NCT01583426clinicaltrials:NCT01641406clinicaltrials:NCT01880385
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Inflammatory Breast Neoplasms [clinicaltrials_resource:dd5979061748d9e407dd4e62ead9f247]
Bio2RDF identifier
dd5979061748d9e407dd4e62ead9f247
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:dd5979061748d9e407dd4e62ead9f247
identifier
clinicaltrials_resource:dd5979061748d9e407dd4e62ead9f247
title
Inflammatory Breast Neoplasms
@en
type
label
Inflammatory Breast Neoplasms [clinicaltrials_resource:dd5979061748d9e407dd4e62ead9f247]
@en
Inflammatory Breast Neoplasms